Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $3.418B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1.097B | 32.1% | — | — | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $244M | 7.1% | — | — | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 3,478,612 | $158M | 4.6% | — | — | COM | 76155X100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 3,075,907 | $120M | 3.5% | — | — | COM | 604749101 |
| TYRA | TYRA BIOSCIENCES INC | 4,661,194 | $110M | 3.2% | — | — | COM | 90240B106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $109M | 3.2% | — | — | COM | 68062P106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 2,238,986 | $98.27M | 2.9% | — | — | SPONSORED ADS | 86366E106 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $96.27M | 2.8% | — | — | COM | 230031106 |
| XOMA | XOMA ROYALTY CORPORATION | 3,633,743 | $96.22M | 2.8% | — | — | COM NEW | 98419J206 |
| AXSM | AXSOME THERAPEUTICS INC | 1,046,000 | $94M | 2.7% | — | — | COM | 05464T104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,850,167 | $83.26M | 2.4% | — | — | COM | 74366E102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 7,382,642 | $79.81M | 2.3% | — | — | COM | 35104E100 |
| ACIU | AC IMMUNE SA | 19,522,436 | $73.79M | 2.2% | — | — | SHS | H00263105 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $69.58M | 2.0% | — | — | ORDINARY SHARES | G3855L106 |
| KURA | KURA ONCOLOGY INC | 3,371,761 | $65.88M | 1.9% | — | — | COM | 50127T109 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $59.16M | 1.7% | — | — | COM | 88427A107 |
| IONS | IONIS PHARMACEUTICALS INC | 1,451,879 | $58.16M | 1.7% | — | — | COM | 462222100 |
| ZYME | ZYMEWORKS INC | 4,607,935 | $57.83M | 1.7% | — | — | COM | 98985Y108 |
| — | ESSA PHARMA INC | 8,748,629 | $53.02M | 1.6% | — | — | COM NEW | 29668H708 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,190,107 | $52.88M | 1.5% | — | — | COM | 00847X104 |
| CELC | CELCUITY INC | 3,466,000 | $51.68M | 1.5% | — | — | COM | 15102K100 |
| — | 89BIO INC | 6,811,631 | $50.41M | 1.5% | — | — | COM | 282559103 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $49.36M | 1.4% | — | — | COM | 344174107 |
| GLPG | GALAPAGOS NV | 1,569,422 | $45.18M | 1.3% | — | — | SPON ADR | 36315X101 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,409,993 | $44.67M | 1.3% | — | — | COM | 45166A102 |
| ANNX | ANNEXON INC | 7,000,000 | $41.44M | 1.2% | — | — | COM | 03589W102 |
| CGON | CG ONCOLOGY INC | 994,596 | $37.53M | 1.1% | — | — | COM | 156944100 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $35.55M | 1.0% | — | — | COM | 760273102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $25.26M | 0.7% | — | — | ORDINARY SHARES | N62509109 |
| XNCR | XENCOR INC | 850,000 | $17.09M | 0.5% | — | — | COM | 98401F105 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $15.67M | 0.5% | — | — | COM | 28617K101 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $14.89M | 0.4% | — | — | COM | 89854M101 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $14.86M | 0.4% | — | — | COM | 29286M105 |
| IMUX | IMMUNIC INC | 8,902,972 | $14.69M | 0.4% | — | — | COM | 4525EP101 |
| — | ALLAKOS INC | 16,552,417 | $10.81M | 0.3% | — | — | COM | 01671P100 |
| AVTX | AVALO THERAPEUTICS INC | 967,000 | $9.148M | 0.3% | — | — | COM NEW | 05338F306 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $8.251M | 0.2% | — | — | COM | 45175G108 |
| — | CIDARA THERAPEUTICS INC | 703,065 | $7.558M | 0.2% | — | — | COM NEW | 171757206 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $6.17M | 0.2% | — | — | COM | 23284F105 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6.166M | 0.2% | — | — | COM | 92673K108 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $6.02M | 0.2% | — | — | COM | 92840H400 |
| VSTM | VERASTEM INC | 1,685,219 | $5.039M | 0.1% | — | — | COM NEW | 92337C203 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $4.548M | 0.1% | — | — | COM | 690469101 |
| — | PIERIS PHARMACEUTICALS INC | 257,626 | $4.313M | 0.1% | — | — | COM NEW | 720795202 |
| — | VERVE THERAPEUTICS INC | 650,000 | $3.146M | 0.1% | — | — | COM | 92539P101 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $2.478M | 0.1% | — | — | COM NEW | 78397T202 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $2.136M | 0.1% | — | — | ADS | 60853G106 |
| — | ELEVATION ONCOLOGY INC | 2,966,836 | $1.78M | 0.1% | — | — | COM | 28623U101 |
| — | GLYCOMIMETICS INC | 9,544,262 | $1.613M | 0.0% | — | — | COM | 38000Q102 |
| IVA | INVENTIVA SA | 686,040 | $1.269M | 0.0% | — | — | ADS | 46124U107 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $1.175M | 0.0% | — | — | COM NEW | 88032L605 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804K | 0.0% | — | — | *W EXP 10/31/202 | 29286M113 |
| — | MOLECULAR TEMPLATES INC | 522,238 | $734K | 0.0% | — | — | COM NEW | 608550208 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $728K | 0.0% | — | — | COM NEW | H57830137 |
| FBRX | FORTE BIOSCIENCES INC | 119,282 | $668K | 0.0% | — | — | COM NEW | 34962G208 |